AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2011
Jan 4, 2011
30339_dirs_2011-01-04_3ae49202-1c1c-4d34-9d9c-88b2110e3ad6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2010-12-31
Reporting Person: WEILAND JOHN H (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-12-31 | Phantom Stock Unit | $ | A | 441.1800 | Acquired | Common Stock (441.1800) | Direct |
Footnotes
F1: Awards of phantom stock units are to be settled only in cash upon the reporting person's termination as a director.
F2: Reflects additional Phantom Stock Units credited through dividend reinvestment based on most recent plan statement.
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27